Our phase I program has indicated that oral RSD1235 can be administered safely at clinically relevant dose levels. We have seen in our intravenous (IV) trials that RSD1235 appears to be effective in converting atrial arrhythmia. Since repeat-dose safety is the major barrier to chronic use of anti-arrhythmic drugs, the strong performance of RSD1235 in these safety studies is very encouraging.

Our phase I program has indicated that oral... | Charles Fisher

Our phase I program has indicated that oral RSD1235 can be administered safely at clinically relevant dose levels. We have seen in our intravenous (IV) trials that RSD1235 appears to be effective in converting atrial arrhythmia. Since repeat-dose safety is the major barrier to chronic use of anti-arrhythmic drugs, the strong performance of RSD1235 in these safety studies is very encouraging. - Charles Fisher


Style PublicSecret

Our phase I program has indicated that oral RSD1235 can be administered safely at clinically relevant dose levels. We have seen in our intravenous (IV) trials that RSD1235 appears to be effective in converting atrial arrhythmia. Since repeat-dose safety is the major barrier to chronic use of anti-arrhythmic drugs, the strong performance of RSD1235 in these safety studies is very encouraging. Charles Fisher

Style Modern Green

Our phase I program has indicated that oral RSD1235 can be administered safely at clinically relevant dose levels. We have seen in our intravenous (IV) trials that RSD1235 appears to be effective in converting atrial arrhythmia. Since repeat-dose safety is the major barrier to chronic use of anti-arrhythmic drugs, the strong performance of RSD1235 in these safety studies is very encouraging. Charles Fisher

Style Red Card

Our phase I program has indicated that oral RSD1235 can be administered safely at clinically relevant dose levels. We have seen in our intravenous (IV) trials that RSD1235 appears to be effective in converting atrial arrhythmia. Since repeat-dose safety is the major barrier to chronic use of anti-arrhythmic drugs, the strong performance of RSD1235 in these safety studies is very encouraging. Charles Fisher

Style Classic

Our phase I program has indicated that oral RSD1235 can be administered safely at clinically relevant dose levels. We have seen in our intravenous (IV) trials that RSD1235 appears to be effective in converting atrial arrhythmia. Since repeat-dose safety is the major barrier to chronic use of anti-arrhythmic drugs, the strong performance of RSD1235 in these safety studies is very encouraging. Charles Fisher

Style Default

Our phase I program has indicated that oral RSD1235 can be administered safely at clinically relevant dose levels. We have seen in our intravenous (IV) trials that RSD1235 appears to be effective in converting atrial arrhythmia. Since repeat-dose safety is the major barrier to chronic use of anti-arrhythmic drugs, the strong performance of RSD1235 in these safety studies is very encouraging. Charles Fisher

Style Pinched

Our phase I program has indicated that oral RSD1235 can be administered safely at clinically relevant dose levels. We have seen in our intravenous (IV) trials that RSD1235 appears to be effective in converting atrial arrhythmia. Since repeat-dose safety is the major barrier to chronic use of anti-arrhythmic drugs, the strong performance of RSD1235 in these safety studies is very encouraging. Charles Fisher

Other embedding Options

If you want to embed quote of the day quotes or want to see other display style options visit our sample page to see all the options.

Learn more about Joomla Quotes Extensions and wordpress extensions.

Cut and paste the following quote id in joomla module / wordpress widget options to display this quote in your webpage. Learn more about Joomla Quotes Extensions and wordpress extensions.

The following will embed an image.You can easily copy and paste it in email or presentations etc. If you want to embed quote of the day quotes or want to see other style options visit our sample page to see all the options.


If you are using this quote in any webpage , printmedia or any other places please use the following methods to cite this quotation.

MLA Style Citation
"A quote by Charles Fisher" theysaidso.com,2021. Mar 8, 2021. https://theysaidso.com/quote/charles-fisher-our-phase-i-program-has-indicated-that-oral-rsd1235-can-be-admini
APA Style Citation
"A quote by Charles Fisher" (n.d.). theysaidso.com. Retrieved Mar 8, 2021, from theysaidso.com web site : https://theysaidso.com/quote/charles-fisher-our-phase-i-program-has-indicated-that-oral-rsd1235-can-be-admini
Chicago Style Citation
"A quote by Charles Fisher". theysaidso.com, 2021. https://theysaidso.com/quote/charles-fisher-our-phase-i-program-has-indicated-that-oral-rsd1235-can-be-admini , accessed Mar 8, 2021.